UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

POS0307 FATIGUE IN RHEUMATOID ARTHRITIS PATIENTS IS ASSOCIATED TO SUBJECTIVE BUT NOT OBJECTIVE ASSESSMENTS OF DISEASE ACTIVITY DURING TREATMENT WITH TOCILIZUMAB

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.379-380

2021

Volltextzugriff (PDF)

POS0279 GOUT PATIENTS ACHIEVING RECOMMENDED SERUM URIC ACID LEVELS OVER 5 YEARS OBTAIN LOW SCORES OF ULTRASOUND DEPOSITIONS; RESULTS FROM THE NOR-GOUT STUDY

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.411-412

2024

Volltextzugriff (PDF)

OP0197 CONTINUOUS REDUCTION IN ULTRASOUND DETECTED CRYSTAL DEPOSITIONS OVER 5 YEARS FOLLOW-UP: RESULTS FROM THE NOR-GOUT STUDY

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.91-92

2024

Volltextzugriff (PDF)

AB1338 CALPROTECTIN, A SENSITIVE MARKER OF INFLAMMATION, IS ROBUSTLY ASSESSED IN PLASMA FROM PATIENTS WITH ESTABLISHED RA BY USE OF DIFFERENT LABORATORY METHODS

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1775-1775

2022

Volltextzugriff (PDF)

OP0204 URATE CRYSTAL DEPOSITIONS ARE ASSOCIATED WITH INFLAMMATORY MARKERS AND CAROTID PLAQUES INDICATING SUBCLINICAL INFLAMMATION IN GOUT; BASELINE RESULTS FROM THE NOR-GOUT STUDY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.123-123

2021

Volltextzugriff (PDF)

OP0296 CRYSTAL DEPOSITIONS ASSESSED BY ULTRASOUND AND DECT DECREASE DURING TREATMENT AND PREDICTS REDUCED NUMBERS OF FLARES; TWO-YEARS RESULTS FROM THE NOR-GOUT TREAT-TO-TARGET STUDY

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.192-193

2023

Volltextzugriff (PDF)

POS0139 TWO-YEAR REDUCTION OF URATE LOAD IN DUAL-ENERGY CT DURING A TREAT-TO-TARGET APPROACH IN GOUT PATIENTS: RESULTS FROM A LONGITUDINAL STUDY (NOR-GOUT)

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.281-282

2021

Volltextzugriff (PDF)

AB0122 THE NORA PROJECT - PREDICTION OF THERAPY RESPONSE IN RHEUMATOID ARTHRITIS

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.1090-1090

2021

Volltextzugriff (PDF)

AB0597 CLINICAL AND LABORATORY EXAMINATIONS THE FIRST 3 MONTHS PREDICT REMISSION AT 6 AND 12 MONTHS; RESULTS FROM A COLLABORATIVE STUDY ON TWO NORWEGIAN COHORTS OF EARLY OR ESTABLISHED RHEUMATOID ARTHRITIS

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.1582-1583

2024

Volltextzugriff (PDF)

SAT0659 Is synovial hypertrophy without doppler activity in rheumatoid arthritis joints sensitive to change? – results of a longitudinal ultrasound study

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1179

2018

Volltextzugriff (PDF)

POS0594 NEW INSIGHTS INTO EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS SUBTYPES THROUGH SEROLOGIC BIOMARKER PROFILING – RESULTS FROM THE SCANDRA PROJECT

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.810-811

2024

Volltextzugriff (PDF)

EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs)

Annals of the rheumatic diseases, 2021-07, Vol.80 (7), p.840-847

2021

Volltextzugriff (PDF)

OP0211 Ultrasound shows rapid reduction of uric acid load during a treat-to-target approach in gout patients: results from a longitudinal study (NOR-GOUT)

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.154

2018

Volltextzugriff (PDF)

Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial

Annals of the rheumatic diseases, 2020-10, Vol.79 (10), p.1340-1348

2020

Volltextzugriff (PDF)

POS1377 REFINING AUTOANTIBODY PROFILES IN PATIENTS WITH RHEUMATOID ARTHRITIS – A SCANDINAVIAN STUDY ON 6900 SAMPLES

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.732-733

2024

Volltextzugriff (PDF)

POS0586 ANTI-TYPE II COLLAGEN ANTIBODIES ASSOCIATE WITH HIGH LEVELS OF INFLAMMATION AT DIAGNOSIS BUT WITH GOOD CLINICAL OUTCOME – A STUDY BASED ON THE NORWEGIAN EARLY RHEUMATOID ARTHRITIS ARCTIC COHORT

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.782-783

2024

Volltextzugriff (PDF)

POS0281 FLUCTUATIONS IN SERUM URATE ARE RELATED TO GOUT FLARES IN THE NOR-Gout STUDY

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.384-385

2022

Volltextzugriff (PDF)

Recommendations for the content and conduct of European League Against Rheumatism (EULAR) musculoskeletal ultrasound courses

Annals of the rheumatic diseases, 2008-07, Vol.67 (7), p.1017-1022

2008

Volltextzugriff (PDF)

FRI0566 Ultrasound Demonstrates Tenosynovitis to be Frequent in RA Patients as Well as Being Responsive to Biologic Treatment

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.632-632

2015

Volltextzugriff (PDF)

THU0425 ULTRASOUND DETECTED URATE CRYSTALS DEPOSITIONS ARE ASSOCIATED WITH ELEVATED CALPROTECTIN AND CRP INDICATING SUBCLINICAL INFLAMMATION; BASELINE RESULTS FROM THE NOR-GOUT STUDY

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.451-451

2020

Volltextzugriff (PDF)

AB1106 DO TENDER JOINTS IN PSORIATIC ARTHRITIS REFLECT INFLAMMATION ON ULTRASOUND?

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1842-1843

2020

Volltextzugriff (PDF)

THU0446 SUCCESSFUL TREATMENT OF GOUT IS FREQUENT IN CLINICAL PRACTICE WHEN APPLYING A TREAT-TO-TARGET STRATEGY: RESULTS FROM THE NOR-GOUT STUDY

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.460-460

2020

Volltextzugriff (PDF)

THU0200 Subcutaneous tocilizumab in patients with rheumatoid arthritis; a high number of patients achieve doppler remission after 24 weeks

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.319

2018

Volltextzugriff (PDF)

POS0183 THE EFFECT OF BELIMUMAB ON SRI-4 RESPONSE IN MULTIPLE SUBGROUPS OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A LARGE INTEGRATED ANALYSIS

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.323-323

2022

Volltextzugriff (PDF)

LB0001 Efficacy and Safety of Subcutaneous Belimumab plus Standard Care in Patients with Systemic Lupus Erythematosus (SLE) with Low Complement and Positive Anti-DSDNA

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.70-71

2016

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAnnals Of The Rheumatic Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(62)

Sprache

Englisch
(62)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ovid SocietyJournals and Single Titles
(62)
BMJ journals single titles
(62)
EZB Electronic Journals Library
(51)
BMJ Journals Archiv - DFG Nationallizenzen
(51)
MEDLINE
(3)

Zeitschrift / Serie

Poster Presentations
(6)
Oral Presentations
(3)

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

POS0307 FATIGUE IN RHEUMATOID ARTHRITIS PATIENTS IS ASSOCIATED TO SUBJECTIVE BUT NOT OBJECTIVE ASSESSMENTS OF DISEASE ACTIVITY DURING TREATMENT WITH TOCILIZUMAB

POS0279 GOUT PATIENTS ACHIEVING RECOMMENDED SERUM URIC ACID LEVELS OVER 5 YEARS OBTAIN LOW SCORES OF ULTRASOUND DEPOSITIONS; RESULTS FROM THE NOR-GOUT STUDY

OP0197 CONTINUOUS REDUCTION IN ULTRASOUND DETECTED CRYSTAL DEPOSITIONS OVER 5 YEARS FOLLOW-UP: RESULTS FROM THE NOR-GOUT STUDY

AB1338 CALPROTECTIN, A SENSITIVE MARKER OF INFLAMMATION, IS ROBUSTLY ASSESSED IN PLASMA FROM PATIENTS WITH ESTABLISHED RA BY USE OF DIFFERENT LABORATORY METHODS

OP0204 URATE CRYSTAL DEPOSITIONS ARE ASSOCIATED WITH INFLAMMATORY MARKERS AND CAROTID PLAQUES INDICATING SUBCLINICAL INFLAMMATION IN GOUT; BASELINE RESULTS FROM THE NOR-GOUT STUDY

OP0296 CRYSTAL DEPOSITIONS ASSESSED BY ULTRASOUND AND DECT DECREASE DURING TREATMENT AND PREDICTS REDUCED NUMBERS OF FLARES; TWO-YEARS RESULTS FROM THE NOR-GOUT TREAT-TO-TARGET STUDY

POS0139 TWO-YEAR REDUCTION OF URATE LOAD IN DUAL-ENERGY CT DURING A TREAT-TO-TARGET APPROACH IN GOUT PATIENTS: RESULTS FROM A LONGITUDINAL STUDY (NOR-GOUT)

AB0122 THE NORA PROJECT - PREDICTION OF THERAPY RESPONSE IN RHEUMATOID ARTHRITIS

AB0597 CLINICAL AND LABORATORY EXAMINATIONS THE FIRST 3 MONTHS PREDICT REMISSION AT 6 AND 12 MONTHS; RESULTS FROM A COLLABORATIVE STUDY ON TWO NORWEGIAN COHORTS OF EARLY OR ESTABLISHED RHEUMATOID ARTHRITIS

SAT0659 Is synovial hypertrophy without doppler activity in rheumatoid arthritis joints sensitive to change? – results of a longitudinal ultrasound study

POS0594 NEW INSIGHTS INTO EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS SUBTYPES THROUGH SEROLOGIC BIOMARKER PROFILING – RESULTS FROM THE SCANDRA PROJECT

EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs)

OP0211 Ultrasound shows rapid reduction of uric acid load during a treat-to-target approach in gout patients: results from a longitudinal study (NOR-GOUT)

Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial

POS1377 REFINING AUTOANTIBODY PROFILES IN PATIENTS WITH RHEUMATOID ARTHRITIS – A SCANDINAVIAN STUDY ON 6900 SAMPLES

POS0586 ANTI-TYPE II COLLAGEN ANTIBODIES ASSOCIATE WITH HIGH LEVELS OF INFLAMMATION AT DIAGNOSIS BUT WITH GOOD CLINICAL OUTCOME – A STUDY BASED ON THE NORWEGIAN EARLY RHEUMATOID ARTHRITIS ARCTIC COHORT

POS0281 FLUCTUATIONS IN SERUM URATE ARE RELATED TO GOUT FLARES IN THE NOR-Gout STUDY

Recommendations for the content and conduct of European League Against Rheumatism (EULAR) musculoskeletal ultrasound courses

FRI0566 Ultrasound Demonstrates Tenosynovitis to be Frequent in RA Patients as Well as Being Responsive to Biologic Treatment

THU0425 ULTRASOUND DETECTED URATE CRYSTALS DEPOSITIONS ARE ASSOCIATED WITH ELEVATED CALPROTECTIN AND CRP INDICATING SUBCLINICAL INFLAMMATION; BASELINE RESULTS FROM THE NOR-GOUT STUDY

AB1106 DO TENDER JOINTS IN PSORIATIC ARTHRITIS REFLECT INFLAMMATION ON ULTRASOUND?

THU0446 SUCCESSFUL TREATMENT OF GOUT IS FREQUENT IN CLINICAL PRACTICE WHEN APPLYING A TREAT-TO-TARGET STRATEGY: RESULTS FROM THE NOR-GOUT STUDY

THU0200 Subcutaneous tocilizumab in patients with rheumatoid arthritis; a high number of patients achieve doppler remission after 24 weeks

POS0183 THE EFFECT OF BELIMUMAB ON SRI-4 RESPONSE IN MULTIPLE SUBGROUPS OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A LARGE INTEGRATED ANALYSIS

LB0001 Efficacy and Safety of Subcutaneous Belimumab plus Standard Care in Patients with Systemic Lupus Erythematosus (SLE) with Low Complement and Positive Anti-DSDNA

Aktive Filter

Suchergebnisse filtern